Standardized SEC financial data for ORAGENICS INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001174940 · NYSE · Pharmaceutical Preparations.
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $87K | $132K | $38K | — | — |
| R&D expense | $22.1M | $10.6M | $10.1M | $15.5M | $4.1M | $2.4M |
| SG&A expense | $4.5M | $5.3M | $4.5M | $5.5M | $6.4M | $7.0M |
| Operating income | -$26.6M | -$15.8M | -$14.4M | -$20.9M | -$10.6M | -$9.4M |
| EBITDA | -$26.6M | -$15.7M | -$14.4M | -$20.9M | — | — |
| Interest expense | $11K | $16K | $15K | $31K | $30K | $22K |
| Pretax income | -$26.4M | -$15.7M | -$14.3M | -$20.7M | -$10.6M | -$10.0M |
| Income tax | — | — | — | — | — | $137K |
| Net income | -$26.4M | -$15.7M | -$14.3M | -$20.7M | -$10.6M | -$9.8M |
| EPS (diluted) | — | — | $-7.11 | $-9.18 | $-47.88 | $-4.56 |
Standardized from ORAGENICS INC's SEC filings — per-share figures split-adjusted. Full history via the API.
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/OGEN/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/OGEN/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"